Association Between Vitamin D Receptor Polymorphism and Serum Vitamin D Levels in Children With Low-Energy Fractures
Sponsor: American Medical Holdings Inc., Staten Island, NY 10314 USA
Listed as NCT02805647, this observational or N/A phase trial focuses on Vitamin D Receptor Defect and remains completed. Sponsored by American Medical Holdings Inc., Staten Island, NY 10314 USA, it has been updated 14 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Dec 2021 — Dec 2022 [monthly]
Completed
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jan 2020 — Nov 2020 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
-
Jun 2018 — Dec 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Medical Holdings Inc., Staten Island, NY 10314 USA
- Medical University of Bialystok
- School of Pharmacy, Creighton University, Omaha, NE 68178 USA
For direct contact, visit the study record on ClinicalTrials.gov .